SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently under pressure as traders react to a now-deleted claim by investor Michael Burry that rival Anthropic is disrupting the company's business model. While community sentiment is heavily polarized between long-term supporters defending the stock's fundamental moat and bears pointing to its high valuation and competition, the stock is seeing significant volatility as investors weigh the impact of these narratives ahead of upcoming earnings.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention following a massive expansion of its long-term cloud infrastructure deal with Meta, now valued at over $35 billion, and a new multi-year partnership with Anthropic to power its Claude AI models. While the community is actively debating the implications of the company's $3.5 billion convertible note offering and its aggressive debt-fueled growth strategy, bullish sentiment remains focused on CoreWeave's cementing of its position as a primary infrastructure provider for the world's leading AI model developers.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is currently a focal point for investors as the company undergoes significant restructuring, including widespread layoffs, to fund an aggressive pivot toward AI-driven data center expansion. While some in the community view these moves as a strategic reallocation of capital to secure long-term growth, many investors are expressing frustration over the stock's persistent downward trend and volatility compared to broader market gains.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing significant selling pressure amid a broader software sector downturn, as investors express growing anxiety over the potential for AI-driven disruption and compressed margins. While many in the community view the stock as deeply undervalued given its strong enterprise adoption and ongoing AI integration, the prevailing sentiment remains cautious as market participants debate whether this price action is a fundamental re-rating or a temporary capitulation ahead of upcoming earnings.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a surge in investor confidence driven by a series of high-profile, multi-year collaboration deals with companies like Google and the integration into Elon Musk's Terafab project. The market is actively discussing a potential valuation re-rating, with traders split between bullish sentiment fueled by these strategic wins and concerns regarding the stock's recent rapid appreciation.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending as investors weigh the stock's recent volatility against an upcoming FDA PDUFA decision for its lead candidate, RP1, in refractory melanoma. Community sentiment is deeply divided, with discussions centered on whether new data and a shifting FDA regulatory landscape will lead to a reversal of the previous Complete Response Letter, or if the stock faces further downside.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as a major momentum play, fueled by aggressive analyst price target hikes and sustained investor excitement over its role in the AI memory infrastructure cycle. While bulls are driving the stock higher on expectations of a potential stock split and supply-side shortages, a vocal segment of the community remains cautious, warning of a potential bubble and comparing the rapid price appreciation to past speculative blow-off tops.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is currently trending as market participants weigh conflicting data, specifically focusing on inflation reports and geopolitical tensions surrounding the Strait of Hormuz. The community is actively debating the sustainability of the current rally, with bulls optimistic about the sector's resilience against macro headwinds while bears remain skeptical of market manipulation and the long-term impact of elevated power constraints and inflation.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is experiencing a parabolic surge driven by massive capacity orders and a structural shift toward photonics as an essential component of AI data center infrastructure. While the community is debating whether this momentum represents a sustainable supercycle or an unsustainable bubble, many are actively monitoring the stock's high volatility and aggressive institutional positioning.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon is experiencing a significant surge driven by reports of a potential $12 billion acquisition bid from Sun Pharma, with investors closely watching for formal confirmation. The community is actively debating the credibility of these buyout rumors and the potential valuation of the company given its existing debt load and recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PolyPid (NASDAQ:PYPD) Stock Price Up 3.3% - Still a Buy?

PolyPid (NASDAQ:PYPD) Shares Up 3.3% - Should You Buy...

PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Recommendation of "Moderate Buy" from Analysts

PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average...

PolyPid Ltd. (NASDAQ:PYPD) Sees Large Drop in Short Interest

PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 23,749...

Wall Street Zen Upgrades PolyPid (NASDAQ:PYPD) to Hold

Wall Street Zen raised PolyPid from a "sell" rating to a "hold" rating in a research note on Saturday...

PolyPid (NASDAQ:PYPD) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen downgraded PolyPid from a "hold" rating to a "sell" rating in a report on Saturday...

PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Moderate Buy" by Analysts

Shares of PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, MarketBeat...

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 44.8% in January

PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a significant increase in short interest in January. As of January 30th, there was short interest totaling 27,918 shares, an increase of...

PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $13.00 price objective on shares of PolyPid in a research report on Wednesday...

PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS

PolyPid (NASDAQ:PYPD - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.07...

PolyPid Q4 Earnings Call Highlights

PolyPid (NASDAQ:PYPD) said 2025 marked a pivotal year as the company completed its SHIELD II Phase 3 trial and moved D-PLEX100 into the final stages of regulatory preparation, while also advancing...

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.

Current Price	$4.37
Prev Close	$4.23
Open	$4.22
Dividend Yield	0.00%
50-Day Moving Average	$4.36
Beta	0.41
Avg. Volume	54,814.73
PE Ratio	-1.93

52-Week High	$5.12
52-Week Low	$2.44
Market Capitalization	$83.39M
EPS (Annual)	-$2.09
Price to Book	7.25
Revenue Per Employee	$0.00

PYPD
Polypid Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PYPD News

PYPDPolypid Ltd